Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29588385 | 1.00 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL630768 | 0.83 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL19770514 | 0.82 | TOP1 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29532976 | 0.79 | NQO2 (0.41) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1662632 | 0.79 | NQO2 (0.41) | CA1CA2CA7CA9CA12 | |
| SCHEMBL971122 | 0.78 | CA1 (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16055919 | 0.78 | PTPN1 (0.37) | HTR2AHTR2CMAPTALDH1A1HPGD | |
| SCHEMBL6873872 | 0.77 | KDM1A (0.31) | — | |
| SCHEMBL7105909 | 0.77 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL25384973 | 0.77 | L3MBTL1 (0.46) | MAPTALDH1A1HPGDKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110669014-B | Preparation method of oxalagogri intermediate | 重庆医药高等专科学校 | 2021-04-30 | — | — | CN | claimed |
| CN-110669014-A | Preparation method of oxalagogri intermediate | 重庆医药高等专科学校 | 2020-01-10 | — | — | CN | claimed |
| CN-108365264-A | A kind of lithium battery tertiary electrolyte | 湖南博信新能源科技有限公司 | 2018-08-03 | — | — | CN | claimed |
| CN-101020628-A | Preparation method of 2, 4-difluoro-3-hydroxybenzoic acid | CHEN WEIDONG (CN) | 2007-08-22 | — | — | CN | claimed |
| US-20260028354-A1 | TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | REGENT OF THE UNIV OF MICHIGAN (US) | 2026-01-29 | — | — | US | disclosed |
| US-12421191-B2 | 3-hydroxyoxindole derivatives as CRHR2 antagonist | RAQUALIA PHARMA INC. (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-4554948-A1 | TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Regents of the University of Michigan (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025064567-A1 | TRICYCLIC PHENOLS FOR INHIBITION OF RAF KINASES | ENLIVEN INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2025020191-A1 | STEROID COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 珂阑(上海)医药科技有限公司 | 2025-01-30 | — | — | WO | disclosed |
| WO-2025021193-A1 | STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 珂阑(上海)医药科技有限公司 | 2025-01-30 | — | — | WO | disclosed |
| CN-111989321-B | KRAS G12C inhibitors | 米拉蒂治疗股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20240101553-A1 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2024-03-28 | — | — | US | disclosed |
| CN-1447797-A | New process for preparing quinolone-carboxylic acid | DALIAN LYNCHEM CO LTD (CN) | 2003-10-08 | — | — | CN | disclosed |
| US-5223536-A | Pyrethroid-like pesticides | FMC CORPORATION (US) | 1993-06-29 | — | — | US | disclosed |
| WO-1993001715-A1 | 1,4-DIARYL-1-CYCLOPROPYL-4-SUBSTITUTED BUTANES AS INSECTICIDES AND ACARICIDES | FMC CORPORATION (US) | 1993-02-04 | — | — | WO | disclosed |
| EP-0488861-A1 | Process for the preparation of alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1992-06-03 | — | — | EP | disclosed |
| EP-0455545-A1 | Process for the preparation of mono- or polyalkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1991-11-06 | — | — | EP | disclosed |
| EP-0434517-A2 | Process for the preparation of mono- or poly-alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1991-06-26 | — | — | EP | disclosed |
| EP-0434516-A2 | Process for the preparation of mono- or poly-alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1991-06-26 | — | — | EP | disclosed |
| CN-87102455-A | Diphenyl ether derivatives pesticide compound | — | 1988-01-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028354-A1 | TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ESRRA, ESR2, ESRRB | CA1 1445/4885CA2 1166/4885CA7 629/4885 |
| US-12421191-B2 | 3-hydroxyoxindole derivatives as CRHR2 antagonist | CRHR2, CRHR1, CRH | CA1 2346/4885CA2 1310/4885CA7 3480/4885 |
| US-20240101553-A1 | KRAS G12C INHIBITORS | KRAS, NRAS, HRAS | CA1 3612/4885CA2 2065/4885CA7 2361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.